The ALS Association/Northeast ALS Consortium PALS Webinar: 
Actemra Study - Anti-inflammatory treatment for ALS
Shafeeq S. Ladha, M.D., Barrow Neurological Institute
Thursday, February 9, 2017
    3:00 - 4:00 PM EST

Dr. Shafeeq Ladha from Barrow Neurological Institute will review a clinical trial of Actemra in ALS patients. The rationale for using the drug and the role of inflammation in ALS progression will be discussed.
Northeast ALS Consortium | 877-458-0631 | alstrials@partners.org | www.alsconsortium.org